Disrupting the α7nAChR–NR2A protein complex exerts antidepressant-like effects

Abstract Major depressive disorder (MDD) is associated with significant morbidity and mortality. Most antidepressant medications target the serotonin and norepinephrine transporters, but a significant minority of patients do not respond to treatment and novel therapeutic targets are needed. We previ...

Full description

Bibliographic Details
Main Authors: Anlong Jiang, Ping Su, Shupeng Li, Albert H. C. Wong, Fang Liu
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Molecular Brain
Subjects:
Online Access:https://doi.org/10.1186/s13041-021-00817-3
_version_ 1818859590775734272
author Anlong Jiang
Ping Su
Shupeng Li
Albert H. C. Wong
Fang Liu
author_facet Anlong Jiang
Ping Su
Shupeng Li
Albert H. C. Wong
Fang Liu
author_sort Anlong Jiang
collection DOAJ
description Abstract Major depressive disorder (MDD) is associated with significant morbidity and mortality. Most antidepressant medications target the serotonin and norepinephrine transporters, but a significant minority of patients do not respond to treatment and novel therapeutic targets are needed. We previously identified a protein complex composed of the α7 nicotinic acetylcholine receptor (nAChR) and NMDA glutamate receptors (NMDARs), through which α7nAChR upregulates NMDAR function. Disruption of the α7nAChR–NMDAR complex with an interfering peptide blocked α7nAChR-mediated upregulation of NMDAR function and cue-induced reinstatement of nicotine seeking in rat models of relapse. Here we report that disrupting the α7nAChR–NMDAR complex with the interfering peptide also has antidepressant-like effects in the forced swim test (FST), a common rat behaviour screening test for antidepressant effects. Furthermore, the interfering peptide significantly increases extracellular signal-regulated kinase (ERK) activity in the animals subjected to the FST. Our results provide a novel potential therapeutic target for the development of new antidepressant medications.
first_indexed 2024-12-19T09:14:36Z
format Article
id doaj.art-1fe716ab1f0049dd8a20b8d39f2a7f62
institution Directory Open Access Journal
issn 1756-6606
language English
last_indexed 2024-12-19T09:14:36Z
publishDate 2021-07-01
publisher BMC
record_format Article
series Molecular Brain
spelling doaj.art-1fe716ab1f0049dd8a20b8d39f2a7f622022-12-21T20:28:07ZengBMCMolecular Brain1756-66062021-07-0114111110.1186/s13041-021-00817-3Disrupting the α7nAChR–NR2A protein complex exerts antidepressant-like effectsAnlong Jiang0Ping Su1Shupeng Li2Albert H. C. Wong3Fang Liu4Campbell Family Mental Health Research Institute, Centre for Addiction and Mental HealthCampbell Family Mental Health Research Institute, Centre for Addiction and Mental HealthCampbell Family Mental Health Research Institute, Centre for Addiction and Mental HealthCampbell Family Mental Health Research Institute, Centre for Addiction and Mental HealthCampbell Family Mental Health Research Institute, Centre for Addiction and Mental HealthAbstract Major depressive disorder (MDD) is associated with significant morbidity and mortality. Most antidepressant medications target the serotonin and norepinephrine transporters, but a significant minority of patients do not respond to treatment and novel therapeutic targets are needed. We previously identified a protein complex composed of the α7 nicotinic acetylcholine receptor (nAChR) and NMDA glutamate receptors (NMDARs), through which α7nAChR upregulates NMDAR function. Disruption of the α7nAChR–NMDAR complex with an interfering peptide blocked α7nAChR-mediated upregulation of NMDAR function and cue-induced reinstatement of nicotine seeking in rat models of relapse. Here we report that disrupting the α7nAChR–NMDAR complex with the interfering peptide also has antidepressant-like effects in the forced swim test (FST), a common rat behaviour screening test for antidepressant effects. Furthermore, the interfering peptide significantly increases extracellular signal-regulated kinase (ERK) activity in the animals subjected to the FST. Our results provide a novel potential therapeutic target for the development of new antidepressant medications.https://doi.org/10.1186/s13041-021-00817-3α7 Nicotinic acetylcholine receptor (α7nAChR)Extracellular signal-regulated kinase (ERK)Forced swim test (FST)Major depressive disorder (MDD)NMDA glutamate receptors (NMDARs)
spellingShingle Anlong Jiang
Ping Su
Shupeng Li
Albert H. C. Wong
Fang Liu
Disrupting the α7nAChR–NR2A protein complex exerts antidepressant-like effects
Molecular Brain
α7 Nicotinic acetylcholine receptor (α7nAChR)
Extracellular signal-regulated kinase (ERK)
Forced swim test (FST)
Major depressive disorder (MDD)
NMDA glutamate receptors (NMDARs)
title Disrupting the α7nAChR–NR2A protein complex exerts antidepressant-like effects
title_full Disrupting the α7nAChR–NR2A protein complex exerts antidepressant-like effects
title_fullStr Disrupting the α7nAChR–NR2A protein complex exerts antidepressant-like effects
title_full_unstemmed Disrupting the α7nAChR–NR2A protein complex exerts antidepressant-like effects
title_short Disrupting the α7nAChR–NR2A protein complex exerts antidepressant-like effects
title_sort disrupting the α7nachr nr2a protein complex exerts antidepressant like effects
topic α7 Nicotinic acetylcholine receptor (α7nAChR)
Extracellular signal-regulated kinase (ERK)
Forced swim test (FST)
Major depressive disorder (MDD)
NMDA glutamate receptors (NMDARs)
url https://doi.org/10.1186/s13041-021-00817-3
work_keys_str_mv AT anlongjiang disruptingthea7nachrnr2aproteincomplexexertsantidepressantlikeeffects
AT pingsu disruptingthea7nachrnr2aproteincomplexexertsantidepressantlikeeffects
AT shupengli disruptingthea7nachrnr2aproteincomplexexertsantidepressantlikeeffects
AT alberthcwong disruptingthea7nachrnr2aproteincomplexexertsantidepressantlikeeffects
AT fangliu disruptingthea7nachrnr2aproteincomplexexertsantidepressantlikeeffects